Home > Insider Trading > Filing (0001209191-15-069493)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1334365	Yuchun Lee	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-09-01	1,333	$57.27	1,333	No	4	M	Direct
Common Stock	Disposition	2015-09-01	100	$123.92	1,233	No	4	S	Direct
Common Stock	Disposition	2015-09-01	825	$125.35	408	No	4	S	Direct
Common Stock	Disposition	2015-09-01	200	$126.32	208	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2015-09-01	1,333	$0.00	1,333	$57.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,667		2022-09-13	No	4	A	Direct

Footnotes

Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $123.92 (range $123.92 to $123.92).
Open market sales reported on this line occurred at a weighted average price of $125.35 (range $125.01 to $125.81).
Open market sales reported on this line occurred at a weighted average price of $126.32 (range $126.25 to $126.38).
The option vests in 16 quarterly installments from 9/14/2012.